← Leaderboards
Rong Xu
Profectus Biosciences, Inc.
$139,009
Attributed
$139,009
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $69.5K · FY2019–20$100K$75K$50K$25K$0
'19
'20
Funding mix
By agency
NIH$139,009 · 1
By mechanism
R03$139,009 · 1
Top collaborators
No co-investigators on record.
Most similar at Profectus Biosciences, Inc.
Same institution · by research overlap
- Kenneth C Bagley$17,138,207
- Jeffrey Meshulam$8,313,876
Others in their field
Other Emerging Leaders on “Adaptive Immune Response”
- Yunda Huang · Fred Hutchinson Cancer Center$60,648,445
- Scott Hensley · University Of Pennsylvania$49,663,739
- S. Mark Tompkins · University Of Georgia$21,225,203
- Walter Orenstein · Emory University$16,408,221
- Andrew Pekosz · Johns Hopkins University$14,871,138
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
Research focus
Adaptive Immune ResponseAdaptive ImmunityAdjuvantAnimal ModelAnimalsAntibodiesAntibody ResponseAntibody Titer MeasurementAntigensBaseBiological SciencesCell MembraneCellsCollaborationsControl GroupsDevicesDna DeliveryDna VaccinesDoctor Of PhilosophyEffectiveness MeasureElectroporationGenerationsGenetic VaccineAcoustics